Role of the endogenous nitric oxide inhibitor asymmetric dimethylarginine (ADMA) and brain-derived neurotrophic factor (BDNF) in depression and behavioural changes: clinical and preclinical data in chronic kidney disease-Reference-Cited by-同舟云学术

Role of the endogenous nitric oxide inhibitor asymmetric dimethylarginine (ADMA) and brain-derived neurotrophic factor (BDNF) in depression and behavioural changes: clinical and preclinical data in chronic kidney disease

Published:2015-07-13 Issue:10 Volume:30 Page:1699-1705
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrol. Dial. Transplant.

Author:

Kielstein Heike,Suntharalingam Mayuren,Perthel Ronny,Song Rong,Schneider Sabrina M.,Martens-Lobenhoffer Jens,Jäger Kristin,Bode-Böger Stefanie M.,Kielstein Jan T.

Funder

Werner Jackstädt-Stiftung to J.T.K. and H.K

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/30/10/1699/17172585/gfv253.pdf

Reference38 articles.

1. Prevalence of Chronic Kidney Disease in the United States

2. Trends in the Prevalence of Reduced GFR in the United States: A Comparison of Creatinine- and Cystatin C−Based Estimates

3. Moderate Renal Impairment and Risk of Dementia among Older Adults: The Cardiovascular Health Cognition Study